Evidence map›Paper›PMID 31112308›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2019

Novel Role for Claudin-11 in the Regulation of Osteoblasts via Modulation of ADAM10-Mediated Notch Signaling.

Richard C Lindsey, Weirong Xing, Sheila Pourteymoor, Catrina Godwin, Alexander Gow, Subburaman Mohan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Obese-diabetic femaleJBMR plus · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Transcriptomic Signatures of Single-Suture Craniosynostosis Phenotypes.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Targeted Deletion of theFrontiers in endocrinology · 2022
    Article
  13. Review
  14. Targeting claudins in cancer: diagnosis, prognosis and therapy.American journal of cancer research · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Richard C LindseyMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA.
Weirong XingMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA.
Sheila PourteymoorMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA.
Catrina GodwinMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA.
Alexander GowCenter for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
Subburaman MohanMusculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, CA, USA.ORCID 0000-0003-0063-986X
Loma Linda University · USVA Loma Linda Healthcare System · USWayne State University · US

Funding

NIH-LLU Initiative for Maximizing Student DiversityR25GM060507 · NIGMS · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2001 to 2022
$11.3M
Transgenic Approaches to Evaluate IGF-I Role in Peak BMDR01AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH &EDUC · PI MOHAN, SUBBURAMAN · 2003 to 2025
$4.7M
Role and Mechanism of Claudin-11 Action and Signaling in BoneR01AR070806 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2017 to 2023
$1.6M
Hearing loss in claudin 11-null miceR01DC006262 · NIDCD · WAYNE STATE UNIVERSITY · PI GOW, ALEXANDER · 2003 to 2007
$1.2M
BLRD VA IK6 BX005381NIAMS NIH HHS R01 AR048139NIAMS NIH HHS R01 AR070806NIDCD NIH HHS R01 DC006262NIGMS NIH HHS 2 R25 GM060507NIGMS NIH HHS R25 GM060507
6 · The paper itself

Abstract

The claudin (Cldn) family comprises 27 members of 20 to 34 kDa transmembrane tight junction proteins. In addition to Cldns' established canonical role as barriers controlling paracellular flow of molecules, a distinct noncanonical role for them as mediators of cell signaling is now emerging. In our studies evaluating Cldn family expression levels during osteoblast differentiation, Cldn-11 showed the largest increase (60-fold). Immunohistochemistry studies revealed high Cldn-11 expression in trabecular (Tb) bone lining cells. Micro-CT analysis of femurs and vertebrae of Cldn-11 knock-out (KO) mice at 12 weeks of age exhibited a 40% (p < 0.01) reduction in Tb bone volume adjusted for tissue volume compared with control mice, a change caused by significant reductions in Tb number and thickness and increase in Tb separation. Histomorphometry and serum biomarker studies revealed that reduced bone formation, not increased resorption, is the cause for reduced Tb bone volume in the Cldn-11 KO mice. Cldn-11 KO osteoblasts expressed reduced ALP and BSP, whereas Cldn-11 overexpression in MC3T3-E1 cells increased expression of ALP and BSP. Mechanistically, Cldn-11 interacted with tetraspanin (Tspan)3 in osteoblasts, and Tspan3 knockdown reduced osteoblast differentiation. Because members of the Tspan family regulate cell functions via Notch signaling, we evaluated whether Cldn-11/Tspan3 regulates Notch signaling in osteoblasts. Accordingly, Notch targets Hey1 and Hey2 were significantly upregulated in Cldn-11 overexpressing cultures but downregulated in both Cldn-11 KO and Tspan3 knockdown osteoblasts. Because ADAM10 has been shown to interact with Tspan family members to regulate Notch signaling, we evaluated whether Cldn-11 regulates ADAM10 expression. Cldn-11 overexpressing cells express more mature ADAM10, and an ADAM10 inhibitor blocked the Cldn-11 effect on osteoblast differentiation. Based on these data, we propose Cldn-11 as a novel component of an osteoblast cell surface protein complex, comprising Tspan3 and ADAM10, which regulates Notch signaling and cell differentiation. © 2019 American Society for Bone and Mineral Research.

Indexed as

Gene Expression RegulationSignal TransductionADAM10 ProteinAmyloid Precursor Protein SecretasesAnimalsCell DifferentiationClaudinsFemurMembrane ProteinsMiceMice, KnockoutOsteoblastsReceptors, NotchSpineTetraspaninsADAM10 ProteinAdam10 protein, mouseAmyloid Precursor Protein SecretasesClaudinsCldn11 protein, mouseMembrane ProteinsReceptors, NotchTetraspaninsTspan3 protein, mouseADAM10CLAUDIN-11NOTCHOSTEOBLASTSTIGHT JUNCTIONS

Identifiers

PMID31112308
PMCPMC6813858
OpenAlexW2946624471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.